Germany · mRNA Vaccines · Reviewed 2026-10-15

Prof. Dr. Ugur Sahin

Prof. Sahin pioneered synthetic mRNA modification and individualized cancer vaccines at JGU Mainz, leading to the world's first approved mRNA COVID-19 vaccine.

Official faculty profile ↗Research checked, not sponsored

Documented research interests and leadership

Research areas: mRNA Vaccines, Cancer Immunotherapy, Personalized Medicine, T-Cell Immunology
Academic position: Professor of Translational Oncology and Immunology & Co-Founder of BioNTech
Primary university source: Official directory entry ↗
Recruitment status: Not verified. Leadership profile does not imply active vacancies or assistantship availability.

Supervision and contact

Students interested in graduate or doctoral research supervision in mRNA Vaccines, Cancer Immunotherapy, Personalized Medicine are advised to consult formal department application channels.

JGU Mainz guide ↗Biology subject guide ↗Mentorship ↗

Important verification note

Facts reflect official university directory records reviewed 2026-10-15. Faculty recruitment and admissions require formal application.

Reviewed 2026-10-15 · Editorial standards · Report an issue